Denali Therapeutics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2017 | -18.9% | -18.9% | -18.1% |
| FY2018 | -6.6% | -6.6% | -5.5% |
| FY2019 | -50.0% | -50.0% | -35.7% |
| FY2020 | 6.2% | 6.2% | 4.4% |
| FY2021 | -30.2% | -30.2% | -20.7% |
| FY2022 | -31.3% | -31.3% | -22.3% |
| FY2023 | -14.1% | -14.1% | -12.6% |
| FY2024 | -34.4% | -34.4% | -30.8% |
| FY2025 | -50.6% | -50.6% | -44.8% |